XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues:        
Total Revenues $ 87,309 $ 51,632 $ 234,689 $ 263,201
Operating expenses:        
Cost of goods sold 41,289 17,286 101,370 42,970
Research and development 14,131 10,397 33,926 35,261
Selling, general and administrative 41,848 39,975 124,353 126,148
Total operating expenses 97,268 67,658 259,649 204,379
(Loss) income from operations (9,959) (16,026) (24,960) 58,822
Interest expense (22,051) (15,082) (61,968) (42,829)
Loss on extinguishment of debt 0 0 0 (53,235)
Other income, net 677 1,584 2,415 6,815
Net loss $ (31,333) $ (29,524) $ (84,513) $ (30,427)
Net loss per common share - basic (in dollars per share) $ (0.16) $ (0.15) $ (0.43) $ (0.17)
Net loss per common share - diluted (in dollars per share) $ (0.16) $ (0.15) $ (0.43) $ (0.17)
Weighted-average shares outstanding - basic (in shares) 200,736,136 194,930,830 198,153,654 184,366,434
Weighted-average shares outstanding - diluted (in shares) 200,736,136 194,930,830 198,153,654 184,366,434
Comprehensive loss $ (31,333) $ (29,524) $ (84,513) $ (30,427)
Product sales, net        
Revenues:        
Total Revenues 40,659 31,106 115,846 84,164
Collaboration revenue        
Revenues:        
Total Revenues $ 46,650 $ 20,526 $ 118,843 $ 179,037